Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Rating Raised to Market Perform at Raymond James Financial

Posted by Stanley Muller on Nov 10th, 2026

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) was upgraded by stock analysts at Raymond James Financial from an “underperform” rating to a “market perform” rating in a report released on Tuesday, FinViz reports.

Other analysts also recently issued research reports about the company. Barclays assumed coverage on Senseonics Holdings, Inc. Common Stock in a research report on Wednesday, October 7th. They issued an “equal weight” rating and a $10.00 target price on the stock. TD Cowen reissued a “buy” rating and set a $15.00 price target on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, October 27th. Weiss Ratings raised shares of Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. Mizuho decreased their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, July 15th. Finally, Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $13.00.

Read Our Latest Research Report on SENS

Senseonics Holdings, Inc. Common Stock Price Performance

Shares of SENS opened at $9.80 on Tuesday. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $10.64. The stock has a market capitalization of $409.64 million, a P/E ratio of -4.39 and a beta of 1.04. The company has a 50 day moving average of $9.12 and a 200-day moving average of $7.26.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported ($0.50) EPS for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). The business had revenue of $19.56 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. As a group, equities research analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Douglas Roeder purchased 13,953 shares of the stock in a transaction on Wednesday, August 19th. The shares were purchased at an average cost of $8.98 per share, with a total value of $125,297.94. Following the acquisition, the director directly owned 171,191 shares in the company, valued at $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 4.70% of the company’s stock.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Institutional investors and hedge funds have recently made changes to their positions in the company. Integrated Wealth Concepts LLC acquired a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth approximately $36,000. Kestra Advisory Services LLC acquired a new position in Senseonics Holdings, Inc. Common Stock in the 1st quarter valued at $68,000. The Manufacturers Life Insurance Company acquired a new position in Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at $65,000. State of Wyoming bought a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $67,000. Finally, StoneX Group Inc. bought a new position in Senseonics Holdings, Inc. Common Stock during the 3rd quarter worth $128,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

About Senseonics Holdings, Inc. Common Stock

(Get Free Report)

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.